iShares Global Healthcare ETF (NYSEARCA:IXJ) Reaches New 1-Year High – What’s Next?

by · The Markets Daily

Shares of iShares Global Healthcare ETF (NYSEARCA:IXJ – Get Free Report) reached a new 52-week high during trading on Wednesday. The stock traded as high as $114.50 and last traded at $113.8810, with a volume of 32,316 shares trading hands. The stock had previously closed at $111.96.

iShares Global Healthcare ETF Stock Up 2.5%

The stock has a market cap of $4.74 billion, a price-to-earnings ratio of 21.58 and a beta of 0.53. The stock’s 50 day moving average price is $105.03 and its two-hundred day moving average price is $99.15.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in IXJ. Envestnet Asset Management Inc. grew its position in iShares Global Healthcare ETF by 45.2% during the 2nd quarter. Envestnet Asset Management Inc. now owns 148,494 shares of the company’s stock worth $14,609,000 after purchasing an additional 46,194 shares during the period. Royal Fund Management LLC raised its stake in shares of iShares Global Healthcare ETF by 4.8% during the 3rd quarter. Royal Fund Management LLC now owns 101,993 shares of the company’s stock valued at $10,416,000 after buying an additional 4,668 shares during the last quarter. Miller Howard Investments Inc. NY purchased a new position in shares of iShares Global Healthcare ETF during the 3rd quarter valued at about $8,796,000. Commonwealth Equity Services LLC acquired a new position in shares of iShares Global Healthcare ETF in the 3rd quarter valued at about $8,753,000. Finally, Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of iShares Global Healthcare ETF in the 3rd quarter valued at about $4,881,000.

iShares Global Healthcare ETF Company Profile

(Get Free Report)

iShares Global Healthcare ETF (the Fund), formerly iShares S&P Global Healthcare Sector Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Global 1200 Healthcare Sector Index (the Index). The Index measures the performance of companies that Standards & Poor’s Financial Services LLC (S&P) deems to be a part of the consumer staples sector of the economy. It is a subset of the S&P Global 1200 Index. Component companies include healthcare providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.

Read More